Skip to content
CancerIndex

Loading the knowledge graph…

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers — knowledge graph · CancerIndex